Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enexor is a private U.S. clean-energy and carbon-conversion company that develops modular on-site systems to transform organic, biomass, and plastic waste into electricity, thermal energy, and captured biogenic carbon products. Its flagship Bio-CHP platform is a containerized waste-to-energy system designed for rapid deployment, autonomous operation, and behind-the-meter energy generation for industrial, commercial, and institutional users. The company manufactures and prototypes in-house in Tennessee and markets a service model intended to reduce customer upfront capital requirements while delivering waste diversion and energy savings. Enexor is not primarily a life science, biotech, pharma, or healthcare company, although it launched a wholly owned subsidiary, Enexor Health Systems, during the COVID-19 pandemic to manufacture the VENT-LS ventilator under FDA Emergency Use Authorization. The company appears focused today on energy, waste, carbon, and industrial sustainability solutions rather than therapeutics or broader healthcare services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enexor Energy.